Gambling, Resorts & Casinos
Compare Stocks
4 / 10Stock Comparison
BRSL vs AMZN vs MSFT vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
Software - Infrastructure
Internet Content & Information
BRSL vs AMZN vs MSFT vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Gambling, Resorts & Casinos | Specialty Retail | Software - Infrastructure | Internet Content & Information |
| Market Cap | $2.35B | $2.92T | $3.13T | $1.17B |
| Revenue (TTM) | $2.51B | $742.78B | $318.27B | $669M |
| Net Income (TTM) | $147M | $90.80B | $125.22B | $-112M |
| Gross Margin | 47.1% | 50.6% | 68.3% | 22.9% |
| Operating Margin | 29.8% | 11.5% | 46.8% | -18.1% |
| Forward P/E | 14.7x | 34.8x | 25.3x | 52.4x |
| Total Debt | $4.25B | $152.99B | $112.18B | $30M |
| Cash & Equiv. | $1.45B | $86.81B | $30.24B | $281M |
BRSL vs AMZN vs MSFT vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 20 | May 26 | Return |
|---|---|---|---|
| Brightstar Lottery (BRSL) | 100 | 154.6 | +54.6% |
| Amazon.com, Inc. (AMZN) | 100 | 178.6 | +78.6% |
| Microsoft Corporati… (MSFT) | 100 | 207.9 | +107.9% |
| Genius Sports Limit… (GENI) | 100 | 47.4 | -52.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRSL vs AMZN vs MSFT vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRSL is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 2 yrs, beta 0.91, yield 30.8%
- Lower P/E (14.7x vs 25.3x)
- 30.8% yield, 2-year raise streak, vs MSFT's 0.8%, (2 stocks pay no dividend)
AMZN is the clearest fit if your priority is valuation efficiency.
- PEG 1.24 vs MSFT's 1.35
- +43.7% vs GENI's -53.1%
MSFT carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 7.9% 10Y total return vs AMZN's 7.0%
- Lower volatility, beta 0.89, Low D/E 32.7%, current ratio 1.35x
- Beta 0.89, yield 0.8%, current ratio 1.35x
- 39.3% margin vs GENI's -16.7%
GENI is the clearest fit if your priority is growth exposure.
- Rev growth 31.0%, EPS growth -63.0%, 3Y rev CAGR 25.2%
- 31.0% revenue growth vs BRSL's -0.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.0% revenue growth vs BRSL's -0.0% | |
| Value | Lower P/E (14.7x vs 25.3x) | |
| Quality / Margins | 39.3% margin vs GENI's -16.7% | |
| Stability / Safety | Beta 0.89 vs AMZN's 1.51, lower leverage | |
| Dividends | 30.8% yield, 2-year raise streak, vs MSFT's 0.8%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +43.7% vs GENI's -53.1% | |
| Efficiency (ROA) | 19.2% ROA vs GENI's -11.1%, ROIC 24.9% vs -16.6% |
BRSL vs AMZN vs MSFT vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRSL vs AMZN vs MSFT vs GENI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 2 of 6 categories
BRSL leads 1 • AMZN leads 1 • GENI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 1109.5x GENI's $669M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to GENI's -16.7%. On growth, GENI holds the edge at +37.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.5B | $742.8B | $318.3B | $669M |
| EBITDAEarnings before interest/tax | $1.1B | $155.9B | $192.6B | -$50M |
| Net IncomeAfter-tax profit | $147M | $90.8B | $125.2B | -$112M |
| Free Cash FlowCash after capex | -$456M | -$2.5B | $72.9B | $37M |
| Gross MarginGross profit ÷ Revenue | +47.1% | +50.6% | +68.3% | +22.9% |
| Operating MarginEBIT ÷ Revenue | +29.8% | +11.5% | +46.8% | -18.1% |
| Net MarginNet income ÷ Revenue | +5.9% | +12.2% | +39.3% | -16.7% |
| FCF MarginFCF ÷ Revenue | -18.2% | -0.3% | +22.9% | +5.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +16.6% | +18.3% | +37.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -70.1% | +74.8% | +23.4% | +33.8% |
Valuation Metrics
BRSL leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 30.9x trailing earnings, MSFT trades at a 18% valuation discount to AMZN's 37.8x P/E. Adjusting for growth (PEG ratio), AMZN offers better value at 1.35x vs MSFT's 1.64x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.3B | $2.92T | $3.13T | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $2.98T | $3.21T | $924M |
| Trailing P/EPrice ÷ TTM EPS | -1269.00x | 37.82x | 30.86x | -10.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.65x | 34.77x | 25.34x | 52.42x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.35x | 1.64x | — |
| EV / EBITDAEnterprise value multiple | 4.67x | 20.47x | 19.72x | — |
| Price / SalesMarket cap ÷ Revenue | 0.94x | 4.07x | 11.10x | 1.75x |
| Price / BookPrice ÷ Book value/share | 1.57x | 7.14x | 9.15x | 1.68x |
| Price / FCFMarket cap ÷ FCF | — | 378.98x | 43.66x | 18.18x |
Profitability & Efficiency
MSFT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-16 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRSL's 2.67x. On the Piotroski fundamental quality scale (0–9), AMZN scores 6/9 vs GENI's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.2% | +23.3% | +33.1% | -15.5% |
| ROA (TTM)Return on assets | +1.6% | +11.5% | +19.2% | -11.1% |
| ROICReturn on invested capital | +11.7% | +14.7% | +24.9% | -16.6% |
| ROCEReturn on capital employed | +12.9% | +15.3% | +29.7% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 3 |
| Debt / EquityFinancial leverage | 2.67x | 0.37x | 0.33x | 0.04x |
| Net DebtTotal debt minus cash | $2.8B | $66.2B | $81.9B | -$250M |
| Cash & Equiv.Liquid assets | $1.4B | $86.8B | $30.2B | $281M |
| Total DebtShort + long-term debt | $4.3B | $153.0B | $112.2B | $30M |
| Interest CoverageEBIT ÷ Interest expense | 3.66x | 39.96x | 55.65x | -136.57x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSFT five years ago would be worth $17,246 today (with dividends reinvested), compared to $2,536 for GENI. Over the past 12 months, AMZN leads with a +43.7% total return vs GENI's -53.1%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs BRSL's -12.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.6% | +19.7% | -10.8% | -55.8% |
| 1-Year ReturnPast 12 months | -2.4% | +43.7% | -2.1% | -53.1% |
| 3-Year ReturnCumulative with dividends | -33.8% | +156.2% | +39.5% | +17.4% |
| 5-Year ReturnCumulative with dividends | +7.0% | +64.8% | +72.5% | -74.6% |
| 10-Year ReturnCumulative with dividends | +31.3% | +697.8% | +787.7% | -52.4% |
| CAGR (3Y)Annualised 3-year return | -12.8% | +36.8% | +11.7% | +5.5% |
Risk & Volatility
Evenly matched — AMZN and MSFT each lead in 1 of 2 comparable metrics.
Risk & Volatility
MSFT is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than AMZN's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs GENI's 34.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.91x | 1.51x | 0.89x | 1.50x |
| 52-Week HighHighest price in past year | $18.57 | $278.56 | $555.45 | $13.73 |
| 52-Week LowLowest price in past year | $12.02 | $185.01 | $356.28 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +68.3% | +97.3% | +75.8% | +34.7% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 81.1 | 54.0 | 45.3 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 45.5M | 32.5M | 5.6M |
Analyst Outlook
Evenly matched — BRSL and MSFT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BRSL as "Buy", AMZN as "Buy", MSFT as "Buy", GENI as "Buy". Consensus price targets imply 153.9% upside for GENI (target: $12) vs 13.1% for AMZN (target: $307). For income investors, BRSL offers the higher dividend yield at 30.80% vs MSFT's 0.77%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $18.50 | $306.77 | $551.75 | $12.10 |
| # AnalystsCovering analysts | 6 | 94 | 81 | 19 |
| Dividend YieldAnnual dividend ÷ price | +30.8% | — | +0.8% | — |
| Dividend StreakConsecutive years of raises | 2 | — | 19 | 1 |
| Dividend / ShareAnnual DPS | $3.91 | — | $3.23 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +11.5% | 0.0% | +0.6% | 0.0% |
MSFT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BRSL leads in 1 (Valuation Metrics). 2 tied.
BRSL vs AMZN vs MSFT vs GENI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRSL or AMZN or MSFT or GENI a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus -0. 0% for Brightstar Lottery (BRSL). Microsoft Corporation (MSFT) offers the better valuation at 30. 9x trailing P/E (25. 3x forward), making it the more compelling value choice. Analysts rate Brightstar Lottery (BRSL) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRSL or AMZN or MSFT or GENI?
On trailing P/E, Microsoft Corporation (MSFT) is the cheapest at 30.
9x versus Amazon. com, Inc. at 37. 8x. On forward P/E, Brightstar Lottery is actually cheaper at 14. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Amazon. com, Inc. wins at 1. 24x versus Microsoft Corporation's 1. 35x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — BRSL or AMZN or MSFT or GENI?
Over the past 5 years, Microsoft Corporation (MSFT) delivered a total return of +72.
5%, compared to -74. 6% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus GENI's -52. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRSL or AMZN or MSFT or GENI?
By beta (market sensitivity over 5 years), Microsoft Corporation (MSFT) is the lower-risk stock at 0.
89β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately 71% more volatile than MSFT relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for Brightstar Lottery — giving it more financial flexibility in a downturn.
05Which is growing faster — BRSL or AMZN or MSFT or GENI?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus -0. 0% for Brightstar Lottery (BRSL). On earnings-per-share growth, the picture is similar: Amazon. com, Inc. grew EPS 29. 7% year-over-year, compared to -100. 5% for Brightstar Lottery. Over a 3-year CAGR, GENI leads at 25. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRSL or AMZN or MSFT or GENI?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -15. 6% for GENI. At the gross margin level — before operating expenses — MSFT leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRSL or AMZN or MSFT or GENI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Amazon. com, Inc. (AMZN) is the more undervalued stock at a PEG of 1. 24x versus Microsoft Corporation's 1. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Brightstar Lottery (BRSL) trades at 14. 7x forward P/E versus 52. 4x for Genius Sports Limited — 37. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 153. 9% to $12. 10.
08Which pays a better dividend — BRSL or AMZN or MSFT or GENI?
In this comparison, BRSL (30.
8% yield), MSFT (0. 8% yield) pay a dividend. AMZN, GENI do not pay a meaningful dividend and should not be held primarily for income.
09Is BRSL or AMZN or MSFT or GENI better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 0. 8% yield, +787. 7% 10Y return). Genius Sports Limited (GENI) carries a higher beta of 1. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +787. 7%, GENI: -52. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRSL and AMZN and MSFT and GENI?
These companies operate in different sectors (BRSL (Consumer Cyclical) and AMZN (Consumer Cyclical) and MSFT (Technology) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BRSL is a small-cap income-oriented stock; AMZN is a mega-cap quality compounder stock; MSFT is a mega-cap quality compounder stock; GENI is a small-cap high-growth stock. BRSL, MSFT pay a dividend while AMZN, GENI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 18%
- Gross Margin > 13%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.